Temporal lobe volume in bipolar disorder: Relationship with diagnosis and antipsychotic medication use

Abstract Understanding the factors that influence psychotropic can guide reduction in use of these medications. This study described predictors of psychotropics use among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in the EIT-4-BPSD trial. Predictive measures included demographics, agitation, resistiveness to care, depression, cognition, pain, facility factors and state. Overall 63% (n=211) received at least one psychotropic medication, 16% (n=52) an anti-seizure medication, 23% (n=77) an anxiolytic, 30% (n=99) an antidepressant, 2% (n=8) a sedative hypnotic, 28% (n=93) an antipsychotic medication, and 9% (n=29) an opioid. Model testing explained 9 to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore additional factors associated with psychotropic medication use such as beliefs of providers.

Download Full-text

Low-value care: antipsychotic medication use among community-dwelling medicare beneficiaries with Alzheimer’s disease and related dementias and without severe mental illness

Aging & Mental Health ◽

10.1080/13607863.2018.1544211 ◽

2018 ◽

Vol 24 (3) ◽

pp. 504-510

Author(s):

Mona Nili ◽

Chan Shen ◽

Usha Sambamoorthi

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mental Illness ◽

Severe Mental Illness ◽

Antipsychotic Medication ◽

Medication Use ◽

Community Dwelling ◽

Medicare Beneficiaries

Download Full-text

Antipsychotic medication use among working-age first-generation migrants resident in Finland: An administrative data linkage study

Scandinavian Journal of Public Health ◽

10.1177/1403494819841960 ◽

2019 ◽

Vol 48 (1) ◽

pp. 64-71 ◽

Cited By ~ 1

Author(s):

Tania Bosqui ◽

Ari Väänänen ◽

Aki Koskinen ◽

André Buscariolli ◽

Dermot O’reilly ◽

...

Keyword(s):

Middle East ◽

Antipsychotic Medication ◽

North Africa ◽

Social Insurance ◽

Psychotic Disorders ◽

Medication Use ◽

Linkage Study ◽

Working Age ◽

First Generation Migrants ◽

Migrant Groups

Aims: Higher incidence of psychotic disorders in high-income countries for migrants compared with the settled majority has been well established. However, it is less clear to what extent different migrants groups have accessed and utilised mental health care. This study aimed to identify the hazard of antipsychotic medication use in the largest migrant groups in Finland, compared with a Finnish-born comparison group, using high quality datasets maintained by Statistics Finland and Social Insurance Institution Finland, and linking socio-demographic and -economic characteristics to antipsychotic prescription purchases. Methods: The study draws on a representative sample of 33% of the adult working-age population of Finland in 2005 ( n = 1,059,426, 50.2% male, 2.5% migrant). The use of antipsychotic drugs was followed-up from 2005 to 2014. Results: The results show that the hazard of antipsychotic medication purchases differed between migrant groups, with a higher hazard for migrants from North Africa and the Middle East before socio-economic adjustment (men HR 1.19, 95% CI 1.04–1.37; women HR 1.37, 95% CI 1.12–1.66), and a lower hazard for all migrant groups after adjustment for socio-economic characteristics compared with the Finland-born population. Conclusions: The findings suggest that attention should be paid to the lower use of medication for psychotic disorders in some migrant groups, as well as the potential role of social disadvantage for migrants from North Africa and Middle East.

Download Full-text